{"DataElement":{"publicId":"2663830","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy Clinical N Stage","preferredDefinition":"the post-neoadjuvant therapy clinical N stage for a breast tumor, the extent of lymph node involvement of a malignant neoplasm of the breast based on clinical observation using the TMN staging system following treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"BRS_TUM_P_NEO_C_N_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2663809","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy Clinical N Stage","preferredDefinition":"information related to post-neoadjuvant therapy clinical N stage for a breast tumor, the extent of lymph node involvement of a malignant neoplasm of the breast based on clinical observation using the TMN staging system following treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"BRST_TUM_P_NEOAD_C_N","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2663807","version":"1","preferredName":"Post Neoadjuvant Therapy Clinical N Stage","preferredDefinition":"Post; occuring after.:Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C38008:C15665:C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FDF722-4D36-463A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"ONEDATA","dateModified":"2007-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FDF722-4D47-463A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2663824","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Clinical N Stage","preferredDefinition":"the post-neoadjuvant clinical N (nodal) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"BRS_TUM_P_NEO_C_N_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"yN0","valueDescription":"NO REGIONAL LYMPH NODE METASTASIS","ValueMeaning":{"publicId":"2559539","version":"1","preferredName":"NO REGIONAL LYMPH NODE METASTASIS","longName":"2559539","preferredDefinition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN0 TNM Finding v6 and v7","conceptCode":"C73347","definition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5A0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MAESKEB","dateModified":"2018-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D840-4F7D-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yN1","valueDescription":"METASTASIS TO MOVABLE IPSILATERAL AXILLARY LYMPH NODE(S)","ValueMeaning":{"publicId":"2559202","version":"1","preferredName":"METASTASIS TO MOVABLE IPSILATERAL AXILLARY LYMPH NODE(S)","longName":"2559202","preferredDefinition":"METASTASIS TO MOVABLE IPSILATERAL AXILLARY LYMPH NODE(S)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B44F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D84C-4F7D-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yN2","valueDescription":"Metastasis to ipsilateral axillary lymph node(s) fixed or matted, or in clinically apparent* ipsilateral internal mammary nodes in the absence of clinically evident lymph node metastasis","ValueMeaning":{"publicId":"2576674","version":"1","preferredName":"Metastasis to ipsilateral axillary lymph node(s) fixed or matted, or in clinically apparent* ipsilateral internal mammary nodes in the absence of clinically evident lymph node metastasis","longName":"2576674","preferredDefinition":"Metastasis to ipsilateral axillary lymph node(s) fixed or matted, or in clinically apparent* ipsilateral internal mammary nodes in the absence of clinically evident lymph node metastasis * [Note: Clinically apparent is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination or grossly visible pathologically.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F88F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D858-4F7D-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yN2a","valueDescription":"Metastasis in ipsilateral axillary lymph nodes fixed to one another (matted) or to other structures","ValueMeaning":{"publicId":"2576680","version":"1","preferredName":"Metastasis in ipsilateral axillary lymph nodes fixed to one another (matted) or to other structures","longName":"2576680","preferredDefinition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes fixed to one another (matted) or to other structures. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN2a TNM Finding v6 and v7","conceptCode":"C73350","definition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes fixed to one another (matted) or to other structures. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F895-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D864-4F7D-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yN2b","valueDescription":"Metastasis only in clinically apparent* ipsilateral internal mammary nodes and in the absence of clinically evident axillary lymph node metastasis","ValueMeaning":{"publicId":"2576679","version":"1","preferredName":"Metastasis only in clinically apparent* ipsilateral internal mammary nodes and in the absence of clinically evident axillary lymph node metastasis","longName":"2576679","preferredDefinition":"Breast cancer with metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN2b TNM Finding v7","conceptCode":"C88369","definition":"Breast cancer with metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F894-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D870-4F7D-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yN3","valueDescription":"Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me","ValueMeaning":{"publicId":"2576675","version":"1","preferredName":"Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me","longName":"2576675","preferredDefinition":"Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3a TNM Finding v6 and v7","conceptCode":"C73353","definition":"Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F890-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D87C-4F7D-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yN3a","valueDescription":"Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me","ValueMeaning":{"publicId":"2576675","version":"1","preferredName":"Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me","longName":"2576675","preferredDefinition":"Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3a TNM Finding v6 and v7","conceptCode":"C73353","definition":"Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F890-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D888-4F7D-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yN3b","valueDescription":"Metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s)","ValueMeaning":{"publicId":"2576677","version":"1","preferredName":"Metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s)","longName":"2576677","preferredDefinition":"Breast cancer with metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3b TNM Finding v6 and v7","conceptCode":"C73354","definition":"Breast cancer with metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F892-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D894-4F7D-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yN3c","valueDescription":"Metastasis in ipsilateral supraclavicular lymph node(s)","ValueMeaning":{"publicId":"2576676","version":"1","preferredName":"Metastasis in ipsilateral supraclavicular lymph node(s)","longName":"2576676","preferredDefinition":"Breast cancer with metastasis in ipsilateral supraclavicular lymph nodes. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3c TNM Finding v6 and v7","conceptCode":"C49007","definition":"Breast cancer with metastasis in ipsilateral supraclavicular lymph nodes. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F891-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D8A0-4F7D-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"},{"value":"yNX","valueDescription":"REGIONAL LYMPH NODES CANNOT BE ASSESSED (E.G., PREVIOUSLY REMOVED)","ValueMeaning":{"publicId":"2559964","version":"1","preferredName":"REGIONAL LYMPH NODES CANNOT BE ASSESSED (E.G., PREVIOUSLY REMOVED)","longName":"2559964","preferredDefinition":"Breast cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cNX TNM Finding v6 and v7","conceptCode":"C73346","definition":"Breast cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B749-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"34FF29BE-D8AC-4F7D-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"CAMPBELB","dateModified":"2007-07-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FF2988-0FC9-4EF4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"}]},{"publicId":"3886755","version":"1","longName":"Preoperative Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902140","version":"1","longName":"Preoperative","context":"BOLD"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"BOLD","type":"USED_BY","context":"BOLD"}],"ReferenceDocuments":[{"name":"Clinical N Stage","type":"Preferred Question Text","description":"Clinical N Stage","url":null,"context":"CTEP"},{"name":"Neoadjuvant Clinical N Stage","type":"Alternate Question Text","description":"Neoadjuvant Clinical N Stage","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"34FE8BA0-2185-5601-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"LUY","dateModified":"2013-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}